相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research

Published on: June 28, 2024

作为一种功能性营养药的ergothioneine:机制,生物可用性和治疗影响

Rony Abdi Syahputra¹, Amer Ahmed², Asriadi¹

¹Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.

The Journal of nutritional biochemistry

|June 20, 2025

概括

埃尔戈氨酸 (EGT) 是一种在中发现的强效抗氧化剂,具有显著的细胞保护性,抗炎性和神经保护性益处. 它独特的载体增强了吸收,突出了它在治疗慢性疾病和促进健康方面的潜力.

科学领域:

营养科学营养科学
生物化学生物化学
药理学药理学是指药理学的学科.

背景情况:

欧戈氨酸 (EGT) 是一种天然存在的含硫抗氧化剂,具有显著的细胞保护性,抗炎性和神经保护性.
主要在中发现,EGT是稳定的,生物可用,并通过一种特定的载体在哺乳动物组织中高度表达而被吸收.
由反应性氧和物种驱动的氧化压力与心血管疾病,神经退行和癌症等慢性疾病有关.

研究的目的:

提供对欧戈氨酸 (EGT) 的全面分析,涵盖其生物合成,饮食来源,吸收和新陈代谢.
阐明EGT在疾病预防和管理方面的治疗潜力和机制基础.
总结EGT研究的最新进展,以指导未来的研究,并支持其临床和营养应用.

主要方法:

审查有关欧戈氨酸 (EGT) 生物合成,饮食来源和吸收机制的现有文献.
对研究EGT在调节与炎症,亡和细胞平衡相关的信号通路中的作用的临床前和临床研究的分析.
检查EGT参与代谢调节,内皮保护和神经退行衰减的作用.

主要成果:

EGT有效地清除反应性氧和物种,减轻慢性疾病病原发生的氧化应激.
新出现的证据表明EGT调节关键信号通路,参与炎症,亡和细胞平衡.
临床前和临床研究支持EGT在代谢调节,内皮保护和神经保护中的作用.

结论:

欧戈氨酸 (EGT) 显示出作为一种功能性营养药剂的显著治疗潜力,用于疾病预防和管理.
EGT的独特特性和吸收机制需要进一步研究,以便在临床和营养科学中得到更广泛的应用.
本次审查巩固了当前的知识,突出了EGT在打击氧化应激和相关慢性疾病方面的承诺.

关键词:

抗氧化剂是一种抗氧化剂.预防疾病预防疾病埃尔戈西奥尼因 (Ergothioneine) 是一种具有活力的物质.有关营养药品的药物.氧化应激是一种氧化应激.

更多相关视频

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation

Resin-Assisted Capture Coupled with Isobaric Tandem Mass Tag Labeling for Multiplexed Quantification of Protein Thiol Oxidation

Published on: June 21, 2021

相关概念视频

Bioavailability: Overview

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...

Sulfur Assimilation

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...

Factors Affecting Drug Biotransformation: Biological

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

Factors Influencing Bioavailability: First-Pass Elimination

Factors Influencing Bioavailability: First-Pass Elimination

When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...

Drug Biotransformation: Overview

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...